A recent research in
cancer research demonstrates that
tumor-specific
pyruvate kinase M2 (PKM2) plays an important role in chromosome segregation and mitosis progression of
tumor cells. To improve the
drug development of TCM compounds, we aim to identify potent TCM compounds as lead compounds of PKM2 regulators. PONDR-Fit protocol was utilized to predict the disordered disposition in the binding domain of PKM2
protein before virtual screening as the disordered structure in the
protein may cause the side effect and downregulation of the possibility of
ligand to bind with target
protein. MD simulation was performed to validate the stability of interactions between PKM2
proteins and each
ligand after virtual screening. The top TCM compounds,
saussureamine C and
precatorine, extracted from Lycium chinense Mill. and Abrus precatorius L., respectively, have higher binding affinities with target
protein in docking simulation than control. They have stable H-bonds with residues A:Lys311 and some other residues in both chains of PKM2
protein. Hence, we propose the TCM compounds,
saussureamine C and
precatorine, as potential candidates as lead compounds for further study in
drug development process with the PKM2
protein against
cancer.